New York, May 19, 2026, 05:04 (EDT)
Amesite Inc. shares rose sharply before the bell Tuesday. The AI software firm said its NurseMagic product landed its biggest enterprise deal so far, signing a home-care client managing 2,700 patients.
The stock ended Monday at $0.7861, off 4.6%. Then, third-party market data put it at $2.50 in premarket trading at 4:53 a.m. EDT, up 218%. Premarket is the lighter trading window before the regular Nasdaq session, and prices can swing on low volume.
Amesite waited until after the bell on Monday to say it landed a new customer. Earlier that day, the company posted its quarterly report. Revenue is still low, and losses haven’t gone away. For a microcap, landing just one enterprise contract can move how the market thinks about size, sometimes before the dollar amount is even out.
Amesite said an unnamed customer plans to roll out NurseMagic AI documentation to its workforce and integrate it with both an EMR system and EVV technology for confirming home care visits. Amesite called the 2,700-patient rollout an increase in scale for NurseMagic.
Dr. Ann Marie Sastry, CEO, said the deployment “validates the strength of our architecture.” Sarah Berman, principal finance and accounting officer, mentioned “same financial discipline.” Madison Bush, director of corporate operations, said there’s a “growing volume of inbound interest.” Amesite, Inc.
Amesite posted $83,332 in revenue for the quarter ended March 31, up from $30,690 in the same period last year. Net loss widened to $678,061 compared to a loss of $663,418 a year ago.
Revenue for the nine months ended March 31 came in at $285,678, up from $54,700 a year earlier. Operating expenses dropped to $2.38 million from $2.80 million. As of March 31, cash and restricted cash stood at $740,711, before the company’s April financing, according to the filing.
More players are moving in. Abridge claims its platform uses AI to turn patient-clinician talks into billable notes. Suki says its product offers ambient documentation, producing clinical notes that can be sent straight into electronic health record systems. Amesite is focusing on non-acute and home-care workflows, not just hospital physician notes.
The rally faces clear risks. Amesite left out key contract details like revenue, margin, term and the customer’s name, and the company’s own filing raised “substantial doubt” about its going concern status—so it’s unclear if Amesite can stay afloat without more funding or better cash flow. content.equisolve.net
Amesite said in the filing it closed a registered direct offering and private placements on April 28, bringing in about $2.2 million in net cash proceeds. That provides more liquidity. But investors could keep an eye on whether the new NurseMagic customer starts generating recurring revenue quickly enough to limit further share sales.
Tuesday isn’t a market holiday for U.S. stocks. Nasdaq’s 2026 calendar puts the next closure at Memorial Day, May 25. With regular trading yet to start, the first move would come at the open.
